KMT2A and acute myeloid leukemia: Our analysis indicated that KDM4A was expressed at significantly higher levels in four AML subtypes than normal mononuclear cell controls, while KDM4C was expressed at only slightly higher levels in AML with MLL-amplification than in controls.